Stability and Compatibility of Ramosetron With Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s244439
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Informa UK Limited